Table 1.
Details of 99mTc-MAA imaging and 90Y bremsstrahlung.
Fig 1.
Gamma counts measurement in SPECT/CT after establishing ROI on CT scan with the longest tumor diameter.
Fig 2.
“Tumor-to-normal-tissue-ratio in the phantom: phT/N” in particular layers of sphere No.1 of IEC-phantom.
There is no significant difference between T/N ratio of median layer (red) and mean phantom total T/N ratio of sphere No. 1. (p = 0.148, Student t-test).
Table 2.
Phantom data.
Table 3.
Patient clinical and treatment data.
Table 4.
Radiological response parameters and the dosimetric calculations for each tumor.
Fig 3.
Evaluation of time to tumor progression (TTPtumor) for the threshold of mT/N1 higher or lower than 1.7 (left) and PAD higher or lower than 70Gy (right).
Fig 4.
Tumor prognosed absorbed dose (a) and tumor actual absorbed dose (b) distribution depending on tumor response. Tumor prognosed absorbed dose (a) and tumor actual absorbed dose (b) distribution depending on tumor size (threshold at 20mm).
Fig 5.
The multivariate correspondence analysis (MCA) for tumors with complete response (CR) and disease progression (PD).